Bradley W. Caprathe - Concepedia

Author

Bradley W. Caprathe

Also Known As

B W Caprathe, B. Caprathe, B. W. CAPRATHE, B.W Caprathe, B.W. Caprathe, Bradley Caprathe, Bradley W. Caprathe, Bradley. W. Caprathe

Publications

957

Citations

H-Index

Concepts

All Affiliations

Warde Medical Laboratory Pfizer (United States)University of Michigan

About

Bradley W. Caprathe is an author at Warde Medical Laboratory specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	788
2	Natural Sciences	11	11	696
3	Biochemistry	10	10	398
4	Engineering	1	1	17
5	Social Sciences	1	1	43

Bradley W. Caprathe

Publications

915

Citations

H-Index

Page 1

	Year	Citations
4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines: a novel class of compounds with central dopamine agonist properties Juan C. Jaén, Lawrence D. Wise, Bradley W. Caprathe, Journal of Medicinal Chemistry Active DopamineOrganic ChemistryPharmacotherapyChemistryHeterocycle Chemistry	1990	254
2-Amino-4<i>H</i>-3,1-benzoxazin-4-ones as Inhibitors of C1r Serine Protease Sheryl J. Hays, Bradley W. Caprathe, John L. Gilmore, Journal of Medicinal Chemistry Combinatorial ChemistryComplement Enzyme C1rMedicinal ChemistryC1r Serine ProteaseBioorganic Chemistry	1998	157
Amnesia-reversal activity of a series of cyclic imides Donald E. Butler, James D. Leonard, Bradley W. Caprathe, Journal of Medicinal Chemistry	1987	66
The design and synthesis of sulfonamides as caspase-1 inhibitors William G. Harter, Hans Albrect, Kenneth D. Brady, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal ChemistryBioorganic ChemistryCaspase-1 InhibitorsMedicine	2003	57
The synthesis and structure–activity relationship of substituted N-phenyl anthranilic acid analogs as amyloid aggregation inhibitors Lloyd J. Simons, Bradley W. Caprathe, Michael J. Callahan, Bioorganic & Medicinal Chemistry Letters Structure–activity RelationshipMedicinal ChemistryBiochemistryNatural SciencesMedicine	2008	45
Dopamine autoreceptor agonists as potential antipsychotics. 3. 6-Propyl-4,5,5a,6,7,8-hexahydrothiazolo[4,5-f]quinolin-2-amine Bradley W. Caprathe, Juan C. Jaén, Lawrence D. Wise, Journal of Medicinal Chemistry Psychotropic MedicationPsychopharmacologyPharmacotherapySocial SciencesMolecular Pharmacology	1991	43
Synthesis and evaluation of 2-aryl-4H-3,1-benzoxazin-4-ones as C1r serine protease inhibitors John L. Gilmore, Sheryl J. Hays, Bradley W. Caprathe, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryNatural SciencesMedicineDrug Development	1996	39
PD-90780, a Nonpeptide Inhibitor of Nerve Growth Factor′s Binding to the P75 NGF Receptor K. Spiegel, Dimitris K. Agrafiotis, Bradley W. Caprathe, Biochemical and Biophysical Research Communications Signal TransductionG Protein-coupled ReceptorMedicineP75 Ngf ReceptorImmunology	1995	30
Evaluation of the effects of the enantiomers of reduced haloperidol, azaperol, and related 4-amino-1-arylbutanols on dopamine and .sigma. receptors Juan C. Jaén, Bradley W. Caprathe, Thomas A. Pugsley, Journal of Medicinal Chemistry Reduced HaloperidolPsychotropic MedicationPsychopharmacologyPharmacotherapyMolecular Pharmacology	1993	30
Design and Synthesis of m1-Selective Muscarinic Agonists: (<i>R</i>)-(−)-(<i>Z</i>)-1-Azabicyclo[2.2.1]heptan-3-one, <i>O</i>-(3-(3‘-Methoxyphenyl)-2-propynyl)- oxime Maleate (CI<b>-</b>1017), a Functionally m1-Selective Muscarinic Agonist Haile Tecle, Stephen D. Barrett, David Lauffer, Journal of Medicinal Chemistry PharmacotherapyChemistryHeterocycle ChemistryPharmaceutical ChemistryM1 Selectivity Reside	1998	29

Page 1